Tonix Pharmaceuticals Reports Q3 2026 Operating Results

What Happened
Tonix Pharmaceuticals Holding Corp. announced its operating results for the quarter ended June 30, 2026 in a press release dated August 10, 2026. The company filed a Form 8-K (Item 2.02) on August 10, 2026 to report these quarterly results and incorporated the press release by reference.

Key Details

• Announcement date: August 10, 2026.
• Reporting period: quarter ended June 30, 2026.
• Form 8-K Item: 2.02 (Results of Operations and Financial Condition).
• Exhibit filed: 99.01 — company press release (incorporated by reference).
• The 8-K does not disclose other events such as executive changes or transactions.

Why It Matters
This filing signals that Tonix has released its latest quarterly earnings and operating results; those details (revenue, net income/loss, cash position and any business updates) will be in the attached press release. Retail investors should read the Exhibit 99.01 press release to assess the company’s recent financial performance and any commentary management provided about outlook, runway, or upcoming milestones. Keywords: earnings, quarterly results, operating results, revenue.